{"id":511750,"date":"2021-07-12T08:33:14","date_gmt":"2021-07-12T12:33:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/"},"modified":"2021-07-12T08:33:14","modified_gmt":"2021-07-12T12:33:14","slug":"veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/","title":{"rendered":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth"},"content":{"rendered":"

<\/p>\n

Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth<\/b><\/p>\n

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE<\/a>)–Veracyte, Inc.<\/a> (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers, a seasoned financial executive with a track record for scaling high-growth healthcare businesses, will join the company July 19, reporting to Marc Stapley, Veracyte\u2019s chief executive officer.\n<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210712005237\/en\/<\/a><\/p>\n

\"Rebecca<\/p>\n

Rebecca Chambers has been appointed EVP and Chief Financial Officer of Veracyte. (Photo: Business Wire)<\/p>\n<\/div>\n

\n\u201cWe believe that our recent acquisitions and strategic initiatives have put in place the pieces to execute on Veracyte\u2019s powerful global vision,\u201d said Mr. Stapley. \u201cI\u2019m thrilled to welcome Rebecca to the Veracyte team at this exciting juncture for the company. I can think of no one more qualified to lead our financial organization, enabling us to serve our customers and their patients, while also delivering value for our shareholders.\u201d\n<\/p>\n

\nMs. Chambers has extensive healthcare leadership experience, most recently serving as chief financial officer for Outset Medical, a publicly traded medical technology company focused on reducing the cost and complexity of dialysis. Prior to that, she was with Illumina, where she served in a number of financial roles: as vice president, Financial Planning & Analysis, from 2017 to 2019; as vice president, Investor Relations and Treasury, from 2015 to 2017; and as senior director, Investor Relations, from 2012 to 2015. Previously, Ms. Chambers served as head of Investor Relations and Corporate Communications at Myriad Genetics and, before that, she held various roles in investor relations at Life Technologies. Earlier in her career, she held positions with Bank of America and Millennium Pharmaceuticals, which is now part of Takeda Pharmaceuticals. Ms. Chambers serves on the board of Inari Medical, a medical device company focused on venous diseases. She holds a B.S. from John Carroll University and an M.B.A. from The S.C. Johnson Graduate School of Management at Cornell University.\n<\/p>\n

\n\u201cI am honored to join the Veracyte team in their commitment to improve outcomes for patients all over the world, at every step of their journey,\u201d said Ms. Chambers. \u201cThe company is uniquely positioned in the genomic diagnostics market given its broad menu of clinically meaningful tests, foundation of scientific excellence, and ability to serve patients globally.\u201d\n<\/p>\n

About Veracyte<\/b><\/p>\n

\nVeracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company\u2019s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company\u2019s tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal cancer tests are in development. With Veracyte\u2019s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com<\/a> and follow the company on Twitter (@veracyte).\n<\/p>\n

Cautionary Note Regarding Forward-Looking Statements <\/b><\/p>\n

\nThis press release contains forward-looking statements, including, but not limited to, statements related to Veracyte\u2019s plans, objectives, expectations (financial and otherwise) or intentions with respect to Ms. Chambers\u2019 appointment and Veracyte\u2019s executive leadership and its positioning for future growth, including international growth. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “expect,” “believe,” “should,” \u201csuggest,\u201d “may,” “will” and similar references to future periods. Actual results may differ materially from those projected or suggested in any forward-looking statements. These statements involve risks and uncertainties, which could cause actual results to differ materially from Veracyte\u2019s predictions, and include, but are not limited to: Veracyte\u2019s ability to achieve and maintain Medicare coverage for its tests; the benefits of Veracyte\u2019s tests, the applicability of clinical results to actual outcomes and Veracyte\u2019s proposed acquisition of HalioDx. Additional factors that may impact these forward-looking statements can be found under the caption \u201cRisk Factors\u201d in Veracyte\u2019s Annual Report on Form 10-K filed with the SEC on February 22, 2021 and its subsequent quarterly reports on Form 10-Q. A copy of these documents can be found at the Investors section of Veracyte\u2019s website at www.veracyte.com<\/a>. The risks and uncertainties may be amplified by the COVID-19 pandemic, which has caused significant economic uncertainty. The extent to which the COVID-19 pandemic impacts Veracyte\u2019s businesses, operations, and financial results, including the duration and magnitude of such effects, will depend on numerous factors, which are unpredictable, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. These forward-looking statements speak only as of the date hereof and, except as required by law, Veracyte specifically disclaims any obligation to update these forward-looking statements or reasons why actual results might differ, whether as a result of new information, future events or otherwise.\n<\/p>\n

\nVeracyte, the Veracyte logo, Decipher, Decipher GRID, Afirma, Percepta, Envisia, Prosigna, Lymphmark, \u201cKnow by Design\u201d and \u201cMore about You\u201d are registered trademarks of Veracyte, Inc. and its affiliates in the U.S. and selected countries. nCounter is the registered trademark of NanoString Technologies, Inc. in the U.S. and selected countries and used by Veracyte under license.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210712005237\/en\/<\/a><\/span><\/p>\n

Investor and Media Contact:
\n<\/b>
Tracy Morris
\n
Vice President of Corporate Communications
\n
& Investor Relations
\n
650-380-4413
\n
tracy.morris@veracyte.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Medical Devices Health Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Rebecca Chambers has been appointed EVP and Chief Financial Officer of Veracyte. (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers, a seasoned financial executive with a track record for scaling high-growth healthcare businesses, will join the company July 19, reporting to Marc Stapley, Veracyte\u2019s chief executive officer. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210712005237\/en\/ Rebecca Chambers has been appointed EVP and Chief Financial Officer of Veracyte. (Photo: Business Wire) \u201cWe believe that our recent acquisitions and strategic initiatives have put in place the pieces to execute on Veracyte\u2019s … <\/p>\n

Continue reading “Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511750","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVeracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers, a seasoned financial executive with a track record for scaling high-growth healthcare businesses, will join the company July 19, reporting to Marc Stapley, Veracyte\u2019s chief executive officer. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210712005237\/en\/ Rebecca Chambers has been appointed EVP and Chief Financial Officer of Veracyte. (Photo: Business Wire) \u201cWe believe that our recent acquisitions and strategic initiatives have put in place the pieces to execute on Veracyte\u2019s … Continue reading "Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T12:33:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20210712005237\/en\/890622\/4\/Rebecca_Chambers_Photo_7-21.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth\",\"datePublished\":\"2021-07-12T12:33:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/\"},\"wordCount\":1023,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210712005237\\\/en\\\/890622\\\/4\\\/Rebecca_Chambers_Photo_7-21.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/\",\"name\":\"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210712005237\\\/en\\\/890622\\\/4\\\/Rebecca_Chambers_Photo_7-21.jpg\",\"datePublished\":\"2021-07-12T12:33:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210712005237\\\/en\\\/890622\\\/4\\\/Rebecca_Chambers_Photo_7-21.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210712005237\\\/en\\\/890622\\\/4\\\/Rebecca_Chambers_Photo_7-21.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/","og_locale":"en_US","og_type":"article","og_title":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth - Market Newsdesk","og_description":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, today announced the appointment of Rebecca Chambers as executive vice president and chief financial officer. Ms. Chambers, a seasoned financial executive with a track record for scaling high-growth healthcare businesses, will join the company July 19, reporting to Marc Stapley, Veracyte\u2019s chief executive officer. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210712005237\/en\/ Rebecca Chambers has been appointed EVP and Chief Financial Officer of Veracyte. (Photo: Business Wire) \u201cWe believe that our recent acquisitions and strategic initiatives have put in place the pieces to execute on Veracyte\u2019s … Continue reading \"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-12T12:33:14+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20210712005237\/en\/890622\/4\/Rebecca_Chambers_Photo_7-21.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth","datePublished":"2021-07-12T12:33:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/"},"wordCount":1023,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210712005237\/en\/890622\/4\/Rebecca_Chambers_Photo_7-21.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/","name":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210712005237\/en\/890622\/4\/Rebecca_Chambers_Photo_7-21.jpg","datePublished":"2021-07-12T12:33:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20210712005237\/en\/890622\/4\/Rebecca_Chambers_Photo_7-21.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20210712005237\/en\/890622\/4\/Rebecca_Chambers_Photo_7-21.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-appoints-rebecca-chambers-as-executive-vice-president-and-chief-financial-officer-further-positioning-company-for-global-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511750"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511750\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}